http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2563141-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc9db22958308cf268518499715bd48e |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-999 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0621 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 |
| filingDate | 2010-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65e0ce2fece938ba79d36cf53c94f68a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ff6d761852d1d0f974508c811135d21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63293d93051bc12df3ab87d4f694d6bd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4138c59deb030e776f0c9daacb5002e9 |
| publicationDate | 2015-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2563141-C2 |
| titleOfInvention | Therapeutic agent (y-39983) for corneal endothelial dysfunction |
| abstract | FIELD: medicine, pharmaceutics. n SUBSTANCE: group of inventions refers to medicine. A therapeutic agent for corneal endothelial dysfunction containing (R)-(+)-N-(1H-pyrrolo[2,3-b]pyridin-4-yl)-4-(1-aminoethyl)benzamide <Y-39983> or its pharmacologically acceptable salt (compound (Ia)) as an active ingredient, an agent for corneal endothelial cell adhesion stimulation containing the compound (Ia), a corneal endothelial cell culture medium containing the agent for adhesion stimulation, a corneal graft for endothelial keratoplasty comprising corneal endothelial cells, a frame and the compound (Ia), and a method for producing a corneal endothelial preparation involving the stage of corneal endothelial cell culture with the use of the culture medium. n EFFECT: agent is used for the effective and comfortable treatment of the diseases involving the corneal endothelial cell damage accompanied by in vivo proliferation impairment. n 21 cl, 17 dwg, 10 ex |
| priorityDate | 2009-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 267.